Cite
HARVARD Citation
Dinshaw, L. et al. (2021). Annualized clinical event rates during two-year follow-up are low in 27, 617 atrial fibrillation patients on edoxaban: results from the global noninterventional ETNA-AF program. Europace. p. . [Online].